Design of Macrocyclic Inhibitors of the NEMO/IKKa/b Protein-Protein Interaction
Design of Macrocyclic Inhibitors of the NEMO/IKKa/b Protein-Protein Interaction
批准号:
8292603
负责人:
Adrian Whitty
金额:
$1.2万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2014-07-31
关键词:
AblationAffinityAlgorithmsAttenuatedBindingBiochemicalBiochemistryBiologicalBiological AssayBiologyCellsCharacteristicsChemicalsChronicComplexComputer SimulationDevelopmentDiseaseDrug Delivery SystemsEnsureEquilibriumFluorescence PolarizationGoalsHumanHuman PathologyHyperactive behaviorInflammationInflammatoryKnowledgeLeadLearningLibrariesLigandsLiver MicrosomesMacrocyclic CompoundsMalignant NeoplasmsMeasurableMeasuresMethodologyMethodsMonitorNF-kappa BNaturePathway interactionsPermeabilityPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstancePhosphotransferasesPropertyProteinsPublic HealthReportingSignal PathwaySignal TransductionSiteSolubilitySourceStructureSystemTestingWorkX-Ray Crystallographyaqueousbasecomputational chemistrydesigndrug developmentdrug discoveryexperienceimprovedinhibitor/antagonistnovelnovel strategiesprotein protein interactionpublic health relevancescaffoldsmall moleculestereochemistryvirtual
中文摘要
描述(由申请人提供):总体项目目标是开发新方法,用于发现针对挑战性蛋白质-蛋白质相互作用(PPI)界面的“药物样”小分子抑制剂。它测试了这样的假设,即适当设计的合成大环化合物可以抑制PPI靶点,同时保持良好的药物样性质。测试系统是细胞内PPI目标NF-?B必需调节因子(NEMO)是β-D-半乳糖苷酶抑制剂的一种成分。B激酶(IKK)复合物。慢性NF-?B途径在人类炎症性疾病和癌症中发现。抑制NEMO与IKK的相互作用,作为完全消除所有IKK激酶活性的更有针对性的替代方案,代表了一种有前途的减轻炎症的新方法。三个具体目标是:1。对NEMO的IKK结合结构域进行虚拟片段筛选。一种新的算法(FTMAP)将用于PPI靶位点。这些结果将为新型合成非环状和大环库的设计提供信息,用于合成和测试NEMO抑制剂。2.合成大环化合物和无环抑制剂(来自目标1),并在荧光偏振测定中测试它们对NEMO/IKK结合的抑制。命中将进行生物化学和结构表征,并通过药物化学进一步优化。所有化合物将在测量ADME性质的测定中进行评估(例如,溶解性、细胞渗透性和肝微粒体稳定性)。因此,这些关键药物性质的不同大环设计的结果将独立于它们对NEMO的活性来确定。3.使用生物化学、生物物理学、结构和生物学方法表征有希望的命中物和先导物(来自目标2),以阐明它们与NEMO相互作用的性质,确定它们与靶标产生的结合能的来源,并评估它们作为生物探针和/或药物先导物的效用。项目团队包括强大的专业知识和高度相关的经验,在项目的各个方面,包括计算化学,大环合成,X射线晶体学,药物发现,NF-?B途径生物学。该项目将提供针对PPI靶点的药物发现的理论和方法学进展。它将阐明PPI界面的理化和结构起源以及可药用性的标志,并将建立新的基于计算机片段的方法和合成大环化合物作为药物样抑制剂对这些目标的来源的效用。
公共卫生相关性:该项目的目标是靶向一类特别具有挑战性的药物靶标-蛋白质-蛋白质相互作用-与小分子(即,合成有机)药物。它的目的是抑制NF-?B基本调节剂(NEMO),NF-?B信号通路,其在人类病理如炎性疾病和癌症中被错误调节。抑制这一途径代表了开发有效药物的一种有前途的新方法,因此与公共卫生高度相关。
英文摘要
DESCRIPTION (provided by applicant): The overall project goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces. It tests the hypothesis that appropriately designed synthetic macrocycles can inhibit PPI targets while maintaining good drug-like properties. The test system is the intracellular PPI target NF-?B essential modulator (NEMO), a component of the inhibitor of ?B kinase (IKK) complex. Chronic hyperactivity of the NF-?B pathway is found in human inflammatory diseases and cancers. Inhibiting the interaction of NEMO with IKK, as a more targeted alternative to completely ablating all IKK kinase activity, represents a promising new approach for attenuating inflammation. The three Specific Aims are: 1. Perform a virtual fragment screen of the IKK binding domain of NEMO. A novel algorithm (FTMAP) will be used against the PPI target sites. The results will inform the design of novel synthetic acyclic and macrocyclic libraries for synthesis and testing as NEMO inhibitors. 2. Synthesize macrocycles and acyclic inhibitors (from Aim 1), and test them for inhibition of NEMO/IKK binding in a fluorescence polarization assay. Hits will be characterized biochemically and structurally and further optimized through medicinal chemistry. All the compounds will be assessed in assays that measure ADME properties (e.g., solubility, cell permeability and liver microsome stability). The consequences of different macrocyclic designs for these key pharmaceutical properties will thus be determined independently of their activity against NEMO. 3. Characterize promising hits and leads (from Aim 2) using biochemical, biophysical, structural and biological approaches, to elucidate the nature of their interactions with NEMO, determine the origins of the binding energy they generate with the target, and assess their utility as biological probes and/or drug leads. The project team encompasses strong expertise and highly relevant experience across every aspect of the project, including computational chemistry, macrocycle synthesis, X-ray crystallography, drug discovery, and NF-?B pathway biology. The project will provide theoretical and methodological advances in drug discovery against PPI targets. It will elucidate the physicochemical and structural origins and hallmarks of druggability at a PPI interface, and will establish the utility of novel in silico fragment-based approaches and synthetic macrocycles as sources for drug-like inhibitors against such targets.
PUBLIC HEALTH RELEVANCE: The goal of this project is to target a particularly challenging class of drug targets, - protein-protein interactions - with small molecule (i.e., synthetic organic) drugs. It aims to inhibit NF-?B Essential Modulator (NEMO), a component of the NF-?B signaling pathway, which is misregulated in human pathologies such as inflammatory disease and cancer. Inhibiting this pathway represents a promising new approach for the development of effective drugs and, consequently, is highly relevant to public health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acquisition of a Surface Plasmon Resonance Instrument
-
批准号:10431408
-
项目类别:
-
资助金额:$40.58万
-
财政年份:2022
-
负责人:Adrian Whitty
-
依托单位:
Molecular Mechanism of the NFkappaB Essential Modulator (NEMO) Scaffold Protein Mutated in Human Immunodeficiencies
-
批准号:9177304
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2016
-
负责人:Adrian Whitty
-
依托单位:
Quantitative Analysis of RET Receptor Activation and Signaling
-
批准号:8040986
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
Quantitative Analysis of RET Receptor Activation and Signaling
-
批准号:8223271
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
Design of Macrocyclic Inhibitors of the NEMO/IKKa/b Protein-Protein Interaction
-
批准号:8520334
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
Quantitative Analysis of RET Receptor Activation and Signaling
-
批准号:8412754
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
Design of Macrocyclic Inhibitors of the NEMO/IKKa/b Protein-Protein Interaction
-
批准号:7949556
-
项目类别:
-
资助金额:$38.85万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
Quantitative Analysis of RET Receptor Activation and Signaling
-
批准号:7899606
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
Design of Macrocyclic Inhibitors of the NEMO/IKKa/b Protein-Protein Interaction
-
批准号:8306924
-
项目类别:
-
资助金额:$46.17万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
Design of Macrocyclic Inhibitors of the NEMO/IKKa/b Protein-Protein Interaction
-
批准号:8136901
-
项目类别:
-
资助金额:$44.51万
-
财政年份:2010
-
负责人:Adrian Whitty
-
依托单位:
海外基金